Latest features

Most popular

CPD Articles


  • Galderma initiates six new studies

    International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.

  • Fillerina unveils periorbital treatments

    Needleless topical gel filler, Fillerina, has announced that its original formula has been revised to treat two new skin zones; the eyes and the eyelids.